Katherine M Delaney1, Ronnie Guillet2, Eva K Pressman3, Laura E Caulfield4, Nelly Zavaleta5, Steven A Abrams6, Kimberly O O'Brien1. 1. Division of Nutritional Sciences, Cornell University, Cornell, NY, USA. 2. Division of Neonatology, Department of Pediatrics, University of Rochester School of Medicine, Rochester, NY, USA. 3. Department of Obstetrics and Gynecology, University of Rochester School of Medicine, Rochester, NY, USA. 4. Department of International Health, Johns Hopkins University, Baltimore, MD, USA. 5. Instituto de Investigacion Nutricional, Lima, Peru. 6. Department of Pediatrics, Dell Medical School, University of Texas at Austin, Austin, TX.
Abstract
BACKGROUND: Maternal iron absorption during pregnancy can be evaluated using RBC incorporation of orally administered stable iron isotope. This approach underestimates true maternal absorption of iron as it does not account for absorbed iron that is transferred to the fetus or retained within the placenta. OBJECTIVE: Our objective was to re-evaluate maternal iron absorption after factoring in these losses and identify factors associated with iron partitioning between the maternal, neonatal, and placental compartments. METHODS: This study utilized data from stable iron isotope studies carried out in 68 women during the third trimester of pregnancy. Iron status indicators and stable iron isotopic enrichment were measured in maternal blood, umbilical cord blood, and placental tissue when available. Factors associated with iron isotope partitioning between the maternal, neonatal, and placental compartments were identified. RESULTS: On average, true maternal absorption of iron increased by 10% (from 19% to 21%) after accounting for absorbed iron present in the newborn (P < 0.001), and further increased by 7%, (from 39% to 42%, P < 0.001) after accounting for iron retained within the placenta. On average, 2% of recovered tracer was present in the placenta and 6% was found in the newborn. Net transfer of iron to the neonate was higher in women with lower total body iron (standardized β = -0.48, P < 0.01) and lower maternal hepcidin (standardized β = -0.66, P < 0.01). In women carrying multiple fetuses, neonatal hepcidin explained a significant amount of observed variance in net placental transfer of absorbed iron (R = 0.95, P = 0.03). CONCLUSIONS: Maternal RBC iron incorporation of an orally ingested tracer underestimated true maternal iron absorption. The degree of underestimation was greatest in women with low body iron. Maternal hepcidin was inversely associated with maternal RBC iron utilization, whereas neonatal hepcidin explained variance in net transfer of iron to the neonatal compartment.These trials were registered at clinicaltrials.gov as NCT01019096 and NCT01582802.
BACKGROUND: Maternal iron absorption during pregnancy can be evaluated using RBC incorporation of orally administered stable iron isotope. This approach underestimates true maternal absorption of iron as it does not account for absorbed iron that is transferred to the fetus or retained within the placenta. OBJECTIVE: Our objective was to re-evaluate maternal iron absorption after factoring in these losses and identify factors associated with iron partitioning between the maternal, neonatal, and placental compartments. METHODS: This study utilized data from stable iron isotope studies carried out in 68 women during the third trimester of pregnancy. Iron status indicators and stable iron isotopic enrichment were measured in maternal blood, umbilical cord blood, and placental tissue when available. Factors associated with iron isotope partitioning between the maternal, neonatal, and placental compartments were identified. RESULTS: On average, true maternal absorption of iron increased by 10% (from 19% to 21%) after accounting for absorbed iron present in the newborn (P < 0.001), and further increased by 7%, (from 39% to 42%, P < 0.001) after accounting for iron retained within the placenta. On average, 2% of recovered tracer was present in the placenta and 6% was found in the newborn. Net transfer of iron to the neonate was higher in women with lower total body iron (standardized β = -0.48, P < 0.01) and lower maternal hepcidin (standardized β = -0.66, P < 0.01). In women carrying multiple fetuses, neonatal hepcidin explained a significant amount of observed variance in net placental transfer of absorbed iron (R = 0.95, P = 0.03). CONCLUSIONS: Maternal RBC iron incorporation of an orally ingested tracer underestimated true maternal iron absorption. The degree of underestimation was greatest in women with low body iron. Maternal hepcidin was inversely associated with maternal RBC iron utilization, whereas neonatal hepcidin explained variance in net transfer of iron to the neonatal compartment.These trials were registered at clinicaltrials.gov as NCT01019096 and NCT01582802.
Authors: María Eugenia Flores-Quijano; Irene Montalvo-Velarde; Victor Saul Vital-Reyes; Maricela Rodríguez-Cruz; Mario Enrique Rendón-Macías; Mardia López-Alarcón Journal: Arch Med Res Date: 2016-10 Impact factor: 2.235
Authors: Paolo de Angelis; Richard K Miller; Thomas H Darrah; Philip J Katzman; Eva K Pressman; Tera R Kent; Kimberly O O'Brien Journal: Environ Res Date: 2017-07-14 Impact factor: 6.498
Authors: P F HAHN; E L CAROTHERS; W J DARBY; M MARTIN; C W SHEPPARD; R O CANNON; A S BEAM; P M DENSEN; J C PETERSON; G S McCLELLAN Journal: Am J Obstet Gynecol Date: 1951-03 Impact factor: 8.661
Authors: Melissa F Young; Ian Griffin; Eva Pressman; Allison W McIntyre; Elizabeth Cooper; Thomas McNanley; Z Leah Harris; Mark Westerman; Kimberly O O'Brien Journal: J Nutr Date: 2010-10-27 Impact factor: 4.798
Authors: Shristi Rawal; Stefanie N Hinkle; Wei Bao; Yeyi Zhu; Jagteshwar Grewal; Paul S Albert; Natalie L Weir; Michael Y Tsai; Cuilin Zhang Journal: Diabetologia Date: 2016-11-10 Impact factor: 10.122
Authors: Elizabeth T Abrams; Jesse J Kwiek; Victor Mwapasa; Deborah D Kamwendo; Eyob Tadesse; Valentino M Lema; Malcolm E Molyneux; Stephen J Rogerson; Steven R Meshnick Journal: Malar J Date: 2005-08-25 Impact factor: 2.979
Authors: Veena Sangkhae; Allison L Fisher; Shirley Wong; Mary Dawn Koenig; Lisa Tussing-Humphreys; Alison Chu; Melisa Lelić; Tomas Ganz; Elizabeta Nemeth Journal: J Clin Invest Date: 2020-02-03 Impact factor: 19.456
Authors: Katherine M Delaney; Ronnie Guillet; Eva K Pressman; Tomas Ganz; Elizabeta Nemeth; Kimberly O O'Brien Journal: J Nutr Date: 2021-07-01 Impact factor: 4.687
Authors: Katherine M Delaney; Chang Cao; Ronnie Guillet; Eva K Pressman; Kimberly O O'Brien Journal: Am J Clin Nutr Date: 2022-04-01 Impact factor: 8.472
Authors: Nicole U Stoffel; Michael B Zimmermann; Ana C Cepeda-Lopez; Karla Cervantes-Gracia; Daniel Llanas-Cornejo; Christophe Zeder; Siriporn Tuntipopipat; Sakita Moungmaithong; Narumon Densupsoontorn; Katharina Quack Loetscher; Sueppong Gowachirapant; Isabelle Herter-Aeberli Journal: Am J Clin Nutr Date: 2022-04-01 Impact factor: 7.045